🫀🧬 Just published in @JACCJournals: EP! Excited to share our state-of-the-art review exploring the complex, two-way link between atrial fibrillation and cancer - and why it’s time for precision cardio-oncology Personalized biomarkers, genomics, imaging & AI are reshaping AF

💫 ADALA Trial 💫 LD-DOAC 🆚 DAPT after LAAO #PCRLV ✅ Primary endpoint: Lower with low-dose DOAC. ✅ DRT: Strong early reduction with LD-DOAC; only 1 late DRT after switch to SAPT (vs. multiple with DAPT). ✅ Bleeding: Less overall bleeding with LD-DOAC → SAPT. ✅ Major

⭐Novel insights into an upcoming device for #treatTR at #PCRLV: Right heart remodelling after DUO system presented by N. Hamid 🎯Spacer across TV w/ valve in center 🎯Anchoring via stent in SVC ➡️TANDEM I FIH study showing pos RV remodelling at 30d & 1y;sustained TR⬇️at 2y

Check out our work below in @MyJSCAI! Thankful for mentorship from @ElliottMillerMD and co-authors @JasonKatzMD @AnnGageMD @AndreaElliottUM @BalimSenmanMD @AYOKUNLE_MD @CesarCaraballoC @criticalecho @aniket_rali @carlosalviar @SocietyOfCCC @TradIMYale @YaleIMed

Thankful for @EKoutroumpakis @DSadlerMD & mentors for helping the #AHA25 CardioOnc trainee happy hour become a reality!

How do you manage antiHer2 therapy in pts with low EF 30-40% (that are medically optimized from cardiac perspective)? Clinical N2 Her2+, HR- breast cancer, ECOG 0-1 @stolaney1 @PTarantinoMD @ErikaHamilton9 @sdent_cardioonc @avirupguha @dr_yakupergun @BijoyTelivala #bcsm

Celebrating our cardio-onc family at AHA 25 @AartiAsnaniMD @AnaBaracCardio @datsunian @Dr_Mike_Fradley @avirupguha @ACCinTouch @ICOSociety @CleClinicHVTI @CleveClinicFL @Richardkcheng2 @anita_deswal @DrGuptaD @EKoutroumpakis @DrSFeldman

CardioOncology Trainee Happy hour happening at 4:30 pm today #AHA25. DM me for location! @StefanoByer

Proud to announce @StefanoByer and I have been awarded GAP funding from UIowa-office of Innovation for our #endovascular catheter/wire device for navigating complex atherosclerosis! #interventional #Radiology #IR #Cardiology #neuroIR

Overlooked and Underdiagnosed: Cardiac Sarcoidosis and Unexplained Ventricular Tachycardia and Fibrillation!. Read 👇 #Sarcoidosis #cardiotwitter @aaron_sifuentes @drpaari @PeterFarjoMD @UIowaCVFellows @IowaMed https://t.co/yBSQjCDXpo

Incredibly honored to receive this recognition from @NANETS1 for our work on equity in the care of patients with Neuroendocrine Neoplasms. This award will serve as a constant reminder for me to continue on this path to ensure that we make progress equitable and available to all

Editorial: Cardiac surveillance recommendations after breast cancer treatment remain limited, with evidence suggesting most survivors benefit from primary care focused on prevention and management of traditional cardiovascular risk factors. https://t.co/rnQqFZCgWt

🚨 Carcinoid heart disease!! (CHD) Saw a patient with new NET diagnosis (hepatic mets)- WHO G2. No HF symptoms, no functional symptoms like flushing or diarrhea. No clear primary (pancreas and lung clear on conventional imaging). SSTR PET pending. Obtained a 2D echo (assuming

Thrilled to share our new paper led by Jeremy Chang @UIowa_Surgery and Dr. James Howe! @UIowaCancer @WinshipAtEmory Peritoneal metastases (PM) in small bowel neuroendocrine tumors (SBNETs) are uniquely challenging; patients face worse oncologic outcomes, and complications such

In HFpEF, comorbidities are common and associated with higher mortality SGLT2i therapy use associated with attenuated risks Comorbidity Patterns and Mortality in HFpEF: A Retrospective Longitudi...

Are you ready to lead one of the most exciting journals in cardio-oncology? The European Heart Journal – Cardio-Oncology is accepting applications for its next Editor-in-Chief. This is your chance to influence groundbreaking research, foster global collaboration, and drive the

🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗 https://t.co/ozSx3UwkLN

Bit of an update; this past week I just started my StARR year which is a one-year immersive research experience here @IM_Iowa @IntMedatIowa! An extremely unique and exciting opportunity that is only offered at a handful of residency programs nationwide https://t.co/In9afGvZCq

Thanks for the shoutout @IowaMed Excited to be a part of the Innovation Fellowship! I’m learning a lot and working on applying to some cool medical-device projects! If you are at Iowa and interested in innovations - I’d be happy to tell you more about the program.

Completely Obsessed—Lasker Award winner Michael Welsh (@uiowa) recalls nearly quitting the lab until a surprising late-night result sparked an obsession. The answer brought an "incredible sense of peace" & confirmed his calling as a physician-scientist. #LaskerAwards